MedTrace Logo

The Favorable Impact of HBcAb Positive Grafts on Liver Transplantation for HBV-related HCC

NCT06787534 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6924

Last updated 2025-01-22

No results posted yet for this study

Summary

The utilization of marginal grafts may help alleviate the demand mismatch. However, strategies to optimize the use of hepatitis B core antibody (HBcAb) positive grafts still requires further investigation. This study aims to investigate possible interactions between HBcAb positive grafts, HCC and HBV-related diseases, and long-term patient and graft survival. The study retrospectively analyzed patients undergoing liver transplantation in 8 centers between January 2015 and December 2020.

Conditions

  • Liver Transplantation

Interventions

OTHER

No Interventions

Sponsors & Collaborators

  • Xiao Xu

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2015-06-01
Completion
2023-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06787534 on ClinicalTrials.gov